Medicine and Dentistry
Adverse Event
21%
Biological Marker
8%
Biological Product
14%
Clinical Trial
34%
Cohort Analysis
32%
Cross Sectional Study
12%
DAS28
12%
Disease Activity
32%
Disease Modifying Antirheumatic Drug
11%
Diseases
28%
Effect Size
13%
Fibromyalgia
12%
Gout
18%
Hidradenitis Suppurativa
9%
Hip Osteoarthritis
11%
Inflammatory Arthritis
100%
Intention-to-Treat Analysis
10%
Kinesiotherapy
10%
Knee Injury and Osteoarthritis Outcome Score
8%
Knee Osteoarthritis
58%
Lifestyle Intervention
10%
Low Calorie Diet
11%
Magnetic Resonance Imaging
18%
Maturity Onset Diabetes of the Young
14%
Meta-Analysis
45%
Meta-Regression
14%
Musculoskeletal Disease
13%
Observational Study
15%
Odds Ratio
10%
Osteoarthritis
38%
Outcome Assessment
10%
Outpatient
9%
Patient-Reported Outcome
25%
Placebo
39%
Prevalence
9%
Prognostic Factor
13%
Prospective Cohort Study
21%
Psoriasis
13%
Psoriatic Arthritis
23%
Quality of Life
22%
Randomized Clinical Trial
19%
Randomized Controlled Trial
94%
Resistance Training
9%
Rheumatic Disease
17%
Rheumatoid Arthritis
98%
Rheumatology
47%
Short Form 36
11%
Spondylarthritis
12%
Systematic Review
74%
Urate
9%
Nursing and Health Professions
Adverse Event
11%
Analgesia
7%
Analgesic Agent
8%
Arthritis
6%
Biological Product
11%
Body Mass
7%
Checklist
5%
Cohort Analysis
16%
Confidence Interval
31%
Construct Validity
11%
Cross-Sectional Study
10%
DAS28
6%
Disease Activity
17%
Diseases
22%
Effect Size
9%
Fibromyalgia
12%
Filter
7%
Health Assessment Questionnaire
6%
Health Care Personnel
5%
Hip Osteoarthritis
10%
Inflammation
6%
Inflammatory Arthritis
79%
Intention to Treat Analysis
7%
Kinesiotherapy
7%
Knee Injury and Osteoarthritis Outcome Score
13%
Knee Osteoarthritis
66%
Knee Pain
7%
Low Back Pain
5%
Low Calorie Diet
8%
Meta Analysis
32%
Muscle Strength
6%
Musculoskeletal Disease
12%
Non Insulin Dependent Diabetes Mellitus
6%
Nuclear Magnetic Resonance Imaging
11%
Odds Ratio
7%
Osteoarthritis
38%
Outcome Assessment
11%
Patient-Reported Outcome
17%
Placebo
22%
Practice Guideline
12%
Prospective Cohort Study
11%
Psoriatic Arthritis
11%
Quality of Life
19%
Rheumatic Disease
14%
Rheumatoid Arthritis
79%
Short Form 36
9%
Spondylarthritis
6%
Suppurative Hidradenitis
5%
Systematic Review
51%
Table Salt
9%
Pharmacology, Toxicology and Pharmaceutical Science
Abatacept
5%
Adalimumab
9%
Adverse Event
24%
Analgesic Agent
5%
Arthritis
6%
Biological Marker
8%
Biological Product
25%
C Reactive Protein
6%
Clinical Trial
21%
Cohort Study
23%
Cross-Sectional Study
8%
Disease Activity
23%
Disease Activity Score
10%
Disease Modifying Antirheumatic Drug
11%
Diseases
16%
Etanercept
9%
Fibromyalgia
10%
Glucocorticoid
11%
Gout
9%
Inflammation
8%
Inflammatory Arthritis
85%
Inflammatory Disease
5%
Infliximab
8%
Knee Osteoarthritis
31%
Methotrexate
11%
Monotherapy
6%
Musculoskeletal Disease
10%
Number Needed to Treat
5%
Observational Study
11%
Osteoarthritis
22%
Placebo
36%
Prospective Cohort Study
8%
Psoriasis
9%
Psoriatic Arthritis
21%
Randomized Clinical Trial
10%
Randomized Controlled Trial
64%
Remission
8%
Rheumatic Disease
15%
Rheumatoid Arthritis
83%
Spondylarthritis
6%
Tumor Necrosis Factor Inhibitor
6%
Urate
5%
